Lothar Germeroth

Senior Vice President, Managing Director
Juno Therapeutics GmbH, a Celgene Company
Philipp Nold
Lothar Germeroth is Senior Vice President at Juno Therapeutics Inc., a Celgene Company and Managing Director at Juno Therapeutics GmbH, and joined Juno through the acquisition of Stage Cell Therapeutics in May 2015. Dr. Germeroth has over 25 years of management experience in biotechnology. Dr. Germeroth served as the CEO at IBA GmbH and the COO at Stage Cell Therapeutics GmbH, and served eight years as CEO in three different German Biotech companies (Jerini BioTools GmbH, Chemotopix GmbH, Cytos Proteome Therapeutics GmbH) and as Chief Business Officer at Cytos Biotechnology AG in Switzerland. Dr. Germeroth studied chemistry in Frankfurt/Main and obtained his PhD in Biochemistry in the department of Nobel Prize Laureate Professor Hartmut Michel at the Max-Planck Institute of Biophysics in Frankfurt.

Sessions

October 29 2019, 08:30
 - 09:00
Keynote Address: CAR-T Cells To Treat Solid Tumors Challenges And Progress
October 29 2019, 11:50
 - 12:20
Panel Discussion: Cost-Effectiveness In Cell & Gene Therapy